Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome

References

• National Institute on Alcohol Abuse and Alcoholism web site. Five year strategic plan FY07-11, 2006. Available from: http://pubs.niaaa.nih.gov/publications/StrategicPlan/NIAAASTRATEGICPLAN.htm. [last accessed 3 Oct 2013]
   Google Scholar
• De Wit M, Best AM, Gennings C, Burnham EL, Moss M. Alcohol use disorders increase the risk for mechanical ventilation in medical patients. Alcohol Clin Exp Res 2007;31:1224–1230
   PubMed Web of Science ®Google Scholar
• Monte R, Rabunal R, Casariego E, Lopez-Agreda H, Mateos A, Pertega S. Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital. Alcohol Alcohol 2010;45:151–158
   PubMed Web of Science ®Google Scholar
• Bayard M, Mcintyre J, Hill KR, Woodside J. Alcohol withdrawal syndrome. Am Fam Physician 2004;69:1443–1450
   PubMed Web of Science ®Google Scholar
• Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, Jara G, et al. Management of alcohol withdrawal delirium: an evidence-based practice guideline. Arch Intern Med 2004;164:1405–1412
   PubMed Web of Science ®Google Scholar
• Brathen G, Ben-Menachem E, Brodtkorb E, Galvin R, Garcia-Monco JC, Halasz P, Hillborn M, et al. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol 2005;12:575–581
   PubMed Web of Science ®Google Scholar
• Hack JB, Hoffmann RS, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2006;2:55–60
   PubMedGoogle Scholar
• Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41:263–306
   PubMed Web of Science ®Google Scholar
• Bjorkqvist SE. Clonidine in alcohol withdrawal. Acta Psychiatr Scand 1975;52:256–263
   PubMed Web of Science ®Google Scholar
• Manhem P, Nilsson LH, Moberg AL, Wadstein J, Hökfelt B. Alcohol withdrawal effects of clonidine treatment in sympathetic activity, the renin-aldosterone system, and clinical symptoms. Alcohol Clin Exp Res 1985;9:238–243
   PubMed Web of Science ®Google Scholar
• Ip Yam PC, Forbes A, Kox WJ. Clonidine in the treatment of alcohol withdrawal in the intensive care unit. Br J Anesth 1992;698:106--108
   Google Scholar
• Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010;36:926–939
   PubMed Web of Science ®Google Scholar
• Jaatinen P, Riihioja P, Haapalinna A, Heinonen E, Kiianmaa K, Hervonen A. Prevention of ethanol-induced sympathetic overactivity and degeneration by dexmedetomidine. Alcohol 1995;12:439–446
   PubMed Web of Science ®Google Scholar
• Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A. Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat. Alcohol Clin Exp Res 1997;21:804–808
   PubMed Web of Science ®Google Scholar
• Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A. Dexmedetomidine alleviates withdrawal symptoms in the rat. Alcohol 1997;14:537–544
   PubMed Web of Science ®Google Scholar
• Riihioja P, Jaatinen P, Haapalinna A, Kiianmaa K, Hervonen A. Dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure. Alcohol Clin Exp Res 1999;23:432–438
   PubMed Web of Science ®Google Scholar
• Hospira, Inc. Precedex (dexmedetomidine) package insert. Lake Forest, IL; 2013
   Google Scholar
• Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644–2653
   PubMed Web of Science ®Google Scholar
• Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, et al. Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301:489–499
   PubMed Web of Science ®Google Scholar
• Mazanikov M, Udd M, Kylänpää L, Lindström O, Halttunen J, Pöyhiä R. Dexmedetomidine impairs success of patient-controlled sedation in alcoholics during ERCP: a randomized, double-blind, placebo-controlled study. Surg Endosc 2013;27:2163–2168
   PubMed Web of Science ®Google Scholar
• Bangbade OA. Dexmedetomidine for peri-operative sedation and analgesia in alcohol addiction. Anaesthesia 2006;61:299–300
   Web of Science ®Google Scholar
• Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry 2006;28:362–363
   PubMed Web of Science ®Google Scholar
• Darrouj J, Puri N, Prince E, Lomonaco A, Spevetz A, Gerber DR. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008;42:1703–1705
   PubMed Web of Science ®Google Scholar
• Tang JF, Chen P, Tang EJ, May TA, Stiver SI. Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury. Neurocrit Care 2011;15:175–181
   PubMed Web of Science ®Google Scholar
• Rayner SG, Weinert CR, Peng H, Jepsen S, Broccard AF. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care 2012;2:12
   PubMed Web of Science ®Google Scholar
• DeMuro JP, Botros DG, Wirkowski E, Hanna AF. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series. J Anesth 2012;26:601–605
   PubMed Web of Science ®Google Scholar
• Muzyk AJ, Revollo JY, Rivelli SK. The use of dexmedetomidine in alcohol withdrawal. J Neuropsychiatry Clin Neurosci 2012;24:E45–E46
   Google Scholar
• Frazee EN, Personett HA, Leung JG, Nelson S, Dierkhising RA, Bauer PR. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients. J Crit Care 2014;29:298–302
   PubMed Web of Science ®Google Scholar
• Tolonen J, Rossinen J, Alho H, Harjola V. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med 2013;20:425–427
   PubMed Web of Science ®Google Scholar
• Crispo AL, Daley MJ, Pepin JL, Harford PH, Brown CV. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous infusion sedatives: dexmedetomidine versus benzodiazepines. Pharmacotherapy 2014;34:910–917
   PubMed Web of Science ®Google Scholar
• VanderWeide LA, Foster CJ, MacLaren R, Kiser TH, Fish DN, Mueller SW. Evaluation of early dexmedetomidine addition to the standard of care for severe alcohol withdrawal in the ICU: a retrospective controlled cohort study. J Int Care Med in press
   PubMedGoogle Scholar
• Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL. Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal. Clin Pharmacol 2014;6:171–177
   PubMedGoogle Scholar
• Ludtke KA, Stanley KS, Yount NL, Gerkin RD. Retrospective review of critically ill patients experiencing alcohol withdrawal: dexmedetomidine versus propofol and/or lorazepam continuous infusions. Hosp Pharm 2015;50:208–213
   Google Scholar
• Mueller SW, Preslaski CR, Kiser TH, Fish DN, Lavelle JC, Malkoski SP, MacLaren R. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med 2014;42:1131–1139
   PubMed Web of Science ®Google Scholar
• Ballenger JC, Post RM. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 1978;133:1–14
   PubMed Web of Science ®Google Scholar
• Booth BM, Blow FC. The kindling hypothesis: further evidence from a U.S. national study of alcoholic men. Alcohol Alcohol 1993;28:593–598
   PubMed Web of Science ®Google Scholar
• Nakagawa Y, Iwasaki T. Involvement of benzodiazepine/GABA-A receptor complex in ethanol-induced state-dependent learning in rats. Brain Res 1995;686:70–76
   PubMed Web of Science ®Google Scholar
• Radel M, Goldman D. Pharmacogenetics of alcohol response and alcoholism: the interplay of genes and environmental factors in thresholds for alcoholism. Drug Metab Dispos 2001;29:489–494
   PubMed Web of Science ®Google Scholar
• Wong A, Benedict NJ, Kane-Gill SL. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal. J Crit Care 2015;30:405--409
   PubMed Web of Science ®Google Scholar
• Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother 2009;43:2064–2074
   PubMed Web of Science ®Google Scholar
• Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 2004;38:1130–1135
   PubMed Web of Science ®Google Scholar
• Dasta JF, Kane-Gill SL, Pencina M, Shehabi Y, Bokesch PM, Wisemandle W, Riker RR. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010;38:497–503
   PubMed Web of Science ®Google Scholar
• Eyer F, Schuster T, Felgenhauer N, Pfab R, Strubel T, Saugel B, Zilker T. Risk assessment of moderate to severe alcohol withdrawal – predictors for seizures and delirium tremens in the course of withdrawal. Alcohol Alcohol 2011;46:427–433
   PubMed Web of Science ®Google Scholar
• Maldonado JR, Sher Y, Ashouri JF, Hills-Evans K, Swendsen H, Lolak S, Miller AC. The “Prediction of Alcohol Withdrawal Severity Scale” (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome. Alcohol 2014;48:375–390
   PubMed Web of Science ®Google Scholar
• Ng K, Dahri K, Vhow I, Legal M. Evaluation of an alcohol withdrawal protocol and a preprinted order set at a tertiary care hospital. Can J Hosp Pharm 2011;64:436–445
   PubMedGoogle Scholar